Announcements
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
More ▼
Key statistics
On Friday, IMCD NV (INX:DUS) closed at 129.55, 19.18% above the 52 week low of 108.70 set on Oct 19, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 129.55 |
---|---|
High | 129.55 |
Low | 129.55 |
Bid | 129.70 |
Offer | 130.55 |
Previous close | 129.95 |
Average volume | 10.80 |
---|---|
Shares outstanding | 56.99m |
Free float | 55.99m |
P/E (TTM) | 25.56 |
Market cap | 7.48bn EUR |
EPS (TTM) | 5.13 EUR |
Annual div (ADY) | 2.24 EUR |
---|---|
Annual div yield (ADY) | 1.73% |
Div ex-date | May 16 2024 |
Div pay-date | May 21 2024 |
Data delayed at least 15 minutes, as of Jul 26 2024 07:11 BST.
More ▼